Important: Peptide Supply products are Research Use Only (RUO). This page is for educational discussion of published research—not medical advice and not intended to diagnose, treat, cure, or prevent any disease. See our RUO positioning and disclaimer language across the site.

Quick Navigation

What “Recovery & Repair” Means in Research

In laboratory and preclinical research, “recovery & repair” typically refers to pathways involved in: angiogenesis, cell migration, extracellular matrix (ECM) remodeling, inflammation control, and oxidative stress regulation. Peptides in this category are commonly examined in controlled models (e.g., wound/tendon/soft tissue models) to observe how these signals shift.

Browse the collection here: Recovery & Repair Peptides.

BPC-157 (Body Protection Compound-157)

Product: BPC-157 10mg

What it is

BPC-157 is a 15–amino acid peptide derived from a protective protein found in gastric juice. It’s discussed in research contexts for its relationship to repair signaling, including growth-factor and vascular signaling themes (e.g., VEGF/FGF), angiogenesis, and nitric oxide–related pathways, plus anti-inflammatory/cytoprotective framing.

Why it appears in “repair” discussions

  • Soft tissue / tendon model interest: recurring focus on tendon fibroblast behavior, outgrowth, and migration endpoints.
  • Vascular signaling themes: angiogenesis-related endpoints are common in the mechanistic literature.
  • Inflammation + oxidative stress: frequently discussed as part of cytoprotection framing.

Studies

  • “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration” — Journal of Applied Physiology (2011). (Preclinical/ex vivo tendon-focused study)
  • “Achilles tendon-to-bone functional healing with BPC 157” — Cell and Tissue Research (2008). (Rat model; tendon-to-bone repair outcome emphasis)
  • “BPC-157 and musculoskeletal tissue repair: review of preclinical evidence” — (Review literature; various journals/years). (Summarizes animal/model findings; not equivalent to clinical proof)

View BPC-157 10mg

TB-500 (Thymosin Beta-4)

Product: TB500

What it is

TB-500 is commonly used as a research-market name associated with Thymosin Beta-4 (Tβ4), a 43–amino acid peptide studied for roles in cell migration, angiogenesis, and wound repair signaling. The literature often emphasizes actin dynamics and cellular motility as a mechanistic theme.

Why it appears in “repair” discussions

  • Cell migration + cytoskeletal dynamics: frequently discussed via actin-binding/actin-sequestering framing.
  • Angiogenesis endpoints: commonly measured in wound repair models where vascularization is rate-limiting.
  • Remodeling context: used in research exploring scar/fibrosis pathways (highly model-dependent).

Studies

  • “Thymosin β4 accelerates wound healing” — Journal of Investigative Dermatology (1999). (Rat full-thickness wound model; re-epithelialization/repair endpoints)
  • “Thymosin β4: mechanistic review of migration/angiogenesis signaling” — (Review literature; various journals/years). (Mechanistic overview; not a substitute for clinical outcomes)

View TB500

Glutathione (GSH)

Product: Glutathione

What it is

Glutathione (GSH) is a naturally occurring tripeptide central to cellular redox balance. Unlike many “repair peptides,” glutathione has a larger body of human research (though outcomes vary by population, endpoints, and formulation).

Why it appears in “recovery” discussions

  • Oxidative stress buffering: redox regulation can influence inflammatory cascades and remodeling signals.
  • Detoxification pathways: often discussed in contexts of hepatic/oxidative burden.
  • Human trials exist: useful for biomarker and kinetics discussions (not necessarily “repair” in the tendon sense).

Studies

  • “Effects of Oral Glutathione Supplementation on Systemic Oxidative Stress Biomarkers in Human Volunteers” — Journal of Alternative and Complementary Medicine (2011). (Randomized, double-blind, placebo-controlled trial; biomarker-focused)
  • “Effects of oral glutathione on skin appearances: a randomized placebo-controlled clinical trial” — Journal of the American Academy of Dermatology (2016). (Randomized, placebo-controlled; dermatology endpoints)

View Glutathione

TB500/BPC Blend

Product: TB500/BPC blend

What it is

This is a combination product framed as a multi-pathway exploration tool: cell migration + angiogenesis themes (commonly associated with Tβ4/TB-500) alongside growth-factor/cytoprotection themes (commonly discussed for BPC-157). The “blend” rationale is generally built from each component’s independent literature rather than robust head-to-head combination trials.

Studies

  • “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration” — Journal of Applied Physiology (2011)
  • “Thymosin β4 accelerates wound healing” — Journal of Investigative Dermatology (1999)

View TB500/BPC blend

How Researchers Choose (Without the Hype)

  • If your model is tendon/connective tissue: BPC-157 is frequently selected due to tendon-centric preclinical studies (e.g., Journal of Applied Physiology 2011).
  • If your model is wound closure/angiogenesis: Thymosin β4 / TB-500 has classic wound model literature (e.g., Journal of Investigative Dermatology 1999).
  • If your model is oxidative stress burden: glutathione has human RCT literature focused on oxidative stress biomarkers (e.g., J Altern Complement Med 2011).
  • If your model is multi-pathway exploration: blends may be used experimentally, but interpretability depends on endpoints, controls, and design rigor.

Links & References

Recovery & Repair Collection + Products

Related Guides

Medical Studies Referenced

Browse the full collection: Recovery & Repair Peptides